Global Health
latest news & developmentsSA and Zambia’s HIV shot dilemma: Demand versus supply
South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early…
Aids is no longer exceptional. What happens now?
The International Aids Conference in Rio de Janeiro highlighted a stark reality: the era of Aids exceptionalism is ending amid unprecedented funding cuts. As science delivers…
What the HLM must deliver for Africa
South Africa, a leader in HIV response with the world's largest antiretroviral treatment programme, advocates for sustained and predictable global resourcing at the High-Level…
Why the HLM Matters: I was born with HIV – do not make decisions about me without me
A 22-year-old South African HIV activist, born with the virus, shares her powerful perspective on living with HIV and calls on world leaders at the High-Level Meeting on HIV/Aids…
Why the High-Level Meeting on HIV matters
Diagnosed with HIV in 2000 when it was a death sentence for many Africans, the author reflects on 25 years of the fight against the epidemic. Ahead of the UN High-Level Meeting…
Why the HLM matters: The world cannot afford to lose this moment
The UN General Assembly High-Level Meeting on HIV/Aids is set to address the alarming decline in political will and funding, which threatens to unravel decades of progress in HIV…
From floods to heatwaves: nearly half of children face stacked climate shocks
A new Unicef analysis reveals that nearly half of the world's children, approximately 1.1 billion, are living with multiple, overlapping climate threats. These hazards, including…
Ebola is back. So are the double standards
Just four years after COVID-19, the US is demanding an Ebola quarantine camp in Kenya, while Western countries impose travel bans on African nations. This article explores the…
A cruise ship, hantavirus and global PTSD
The memory of the Covid-19 shock shapes how governments and publics react to any new outbreak with even a hint of international spread
Building toilets, fighting TB: Candice Andisiwe Sehoma’s life of activism
From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients
Mozambican children die after US funding cuts: Who bears responsibility?
The least the Trump administration could have done was provide ample warning that it was going to cut aid
The Global Fund has just made history – now it must start a revolution
Africa’s first locally made HIV treatment is more than a milestone, it’s a political, economic and moral turning point in the fight for health sovereignty
The US’s NIH funds R6.65 billion of research in South Africa
If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity
The six-monthly anti-HIV jab could end Aids in SA by 2032
A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while
South African-Cuban link: Trump’s targets can help each other
There is an urgent need to build health sovereignty and sustainability to break dependence on donations